Senseonics Holdings (SENS) Cash from Financing Activities (2014 - 2026)
Senseonics Holdings' (SENS) quarterly Cash from Financing Activities came in at $3.4 million in Q1 2026, down 44.32% year-on-year from $6.1 million in Q1 2025, and up 210.29% on a QoQ basis from $1.1 million in Q4 2025.
Senseonics Holdings (SENS) Cash from Financing Activities (2014 - 2026) Analysis & Trends
Senseonics Holdings (SENS) has 13 years of Cash from Financing Activities data on file, last reported at $3.4 million in Q1 2026.
- On a quarterly basis, Cash from Financing Activities fell 44.32% year-over-year to $3.4 million in Q1 2026; TTM through Mar 2026 was $75.5 million, a 229.37% increase from a year earlier, with the FY2025 full-year figure at $78.2 million, up 191.42% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $3.4 million, up from $1.1 million in the prior quarter.
- Over the last five years, Cash from Financing Activities for SENS reached as high as $71.1 million in Q2 2025 and fell as low as -$1.8 million in Q2 2022.
- Historically, Cash from Financing Activities has averaged $10.0 million across 5 years, with a median of $5.5 million in 2023.
- Across the five-year window, Cash from Financing Activities tumbled 118.42% in 2024 and jumped 7084.77% in 2025, its largest moves.
- Year by year, Cash from Financing Activities stood at $10.3 million in 2022, then tumbled by 111.39% to -$1.2 million in 2023, then surged by 1294.48% to $14.1 million in 2024, then sank by 92.2% to $1.1 million in 2025, then soared by 210.29% to $3.4 million in 2026.
- Per Business Quant data, the three most recent Cash from Financing Activities figures were $3.4 million in Q1 2026, $1.1 million in Q4 2025, and -$134000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -25.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -26.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Senseonics Holdings | 203.54 Mn | 139.22 Mn | 6.94 Mn | 3.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.41 Mn |
| Mar 31, 2026 | 3.41 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | -134,000.00 |
| Sep 30, 2025 | -134,000.00 |
| Jun 30, 2025 | 71.11 Mn |
| Jun 30, 2025 | 71.11 Mn |
| Mar 31, 2025 | 6.12 Mn |
| Mar 31, 2025 | 6.12 Mn |
| Dec 31, 2024 | 14.07 Mn |
| Dec 31, 2024 | 14.07 Mn |
| Sep 30, 2024 | 3.74 Mn |
| Sep 30, 2024 | 3.74 Mn |
| Jun 30, 2024 | -1.02 Mn |
| Jun 30, 2024 | -1.02 Mn |
| Mar 31, 2024 | 10.03 Mn |
| Mar 31, 2024 | 10.03 Mn |
| Dec 31, 2023 | -1.18 Mn |
| Dec 31, 2023 | -1.18 Mn |